Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency

4 total trials 2 recruiting MedDRA PT

Filter these 4 trials by phase, country, sponsor and more.

Open in Search →

The ENERGY 2 Study: A study to investigate if study drug INZ-701 increases survival in infants with ENPP1 Deficiency by preventing heart dys … Recruiting

2024-512991-36-00 5 2024-10-24 "Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) D"
A Long-term Follow-up Study of Participants who Received INZ-701 in a previous clinical study Recruiting

2024-512715-42-00 4 2024-10-08 "Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) D"
The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency Recruitment ended

2023-507382-26-00 5 2024-05-24 "Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) D"
The ENERGY Study: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Infants with ENPP1 Deficiency … Ended

2023-507384-20-00 3 2024-10-21 "Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) D"

Showing 1–4 of 4 trials